Skip to content

Very Advanced Maternal Aged Pregnants and Early Adolescent Pregnant Women

Comparison of Perinatal and Neonatal Outcomes of Very Advanced Maternal Aged Pregnants and Early Adolescent Pregnant Women

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05484869
Enrollment
297
Registered
2022-08-02
Start date
2017-01-01
Completion date
2021-12-30
Last updated
2022-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Maternal Age Pregnancy, Early Pregnancy

Keywords

age, pregnancy, adolescent, perinatal, neonatal

Brief summary

Maternal age is an important factor affecting the pregnancy process and its results. Adverse obstetric outcomes such as preterm birth, stillbirth, and infant mortality are more common in women older than 35 years and younger than 20 years compared to women aged 20-29. Adolescent pregnancies have been associated with an increased risk of adverse pregnancy outcomes such as preterm birth, low birth weight, perinatal death, and maternal mortality. Advanced maternal age pregnancies were associated with higher rates of maternal hypertension and diabetes, and progressively worsening perinatal outcomes such as stillbirth, preterm birth, and low birth weight. Although the investigators' region has high birth rates, as far as they have observed, the rates of early and advanced maternal age are also quite high. the investigators' aim in this study is to determine the absolute effects of early and advanced maternal age on pregnancy and to investigate the pregnancy outcomes of these mothers.

Detailed description

The investigators' aim in this study is to determine the absolute effects of early and advanced maternal age on pregnancy and to investigate the pregnancy outcomes of these mothers. For this purpose, the information of 90 pregnant women followed in Siirt Training and Research Hospital between 2017-2021 will be accessed through the hospital's data system. Maternal age, pregnancy history, Assisted reproductive technologies history, laboratory findings, screening test results, mode of delivery, baby birth information, pregnancy complications and complications during delivery will be recorded. In the light of the information gathered, the rates of negative effects of gestational age on pregnancy will be calculated.

Interventions

None listed

Sponsors

Siirt University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 47 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnants under the age of 16 and younger * pregnants over the age of 45 and older

Exclusion criteria

* history of chronic hypertension * history of pre gestational diabetes * history of chronic diseases * excessive consumption of alcohol * smoking pregnants * kidney disorders

Design outcomes

Primary

MeasureTime frameDescription
Delivery type in pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthThe % of delivery type (vaginal delivery/ cesarean section) will be compared between the three groups
Abortion ratio of pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of abortion will be compared between the three groups
Neonatal death ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of neonatal death will be compared between the three groups
Premature rupture of membranes in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of premature rupture of membranes (PROM) will be compared between the three groups
Preterm labor ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of preterm labor will be compared between the three groups
Ablatio placentae ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of ablatio placentae will be compared between the three groups
Fetal Distress ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of fetal distress will be compared between the three groups
Intrauterine death ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of intrauterine death will be compared between the three groups
Gestational diabetes ratio in pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of gestational diabetes mellitus (GDM) will be compared between the three groups
Preeclampsia ratio in pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of preeclampsia will be compared between the three groups
Surmaturation ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of surmaturation will be compared between the three groups
Polyhydramnios ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of polyhydramnios will be compared between the three groups
Oligohydramnios ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of oligohydramnios will be compared between the three groups
Presentation anomaly ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of presentation anomaly will be compared between the three groups
Multiple pregnancy ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of multiple pregnancy will be compared between the three groups
Intrauterine growth retardation ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of intrauterine growth retardation (IUGR) will be compared between the three groups
Postpartum hemorrhage ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of postpartum hemorrhage will be compared between the three groups
Placenta previa ratio in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthRate and % of placenta previa will be compared between the three groups
Mean fetal weight of pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1monthThe fetal weight (in grams) will be compared between the three groups
Ratio of male, female gender in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 month% of male, female gender will be compared between the three groups
Mean APGAR scores in the 1st minute in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthAPGAR scores in the 1st minute (by numbers) will be compared between the three groups
Mean APGAR scores in the 5th minute in pregnancies of pregnant women under the age of 16 ( group 1), over the age of 45 (group 2) and between the age of 25-35 (group 3).1 monthAPGAR scores in the 5th minute (by numbers) will be compared between the three groups

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026